MedPath

Phase I/II study of stereotactic radiotherapy for renal cell cancer

Phase 1
Recruiting
Conditions
Renal cell cancer
Registration Number
JPRN-UMIN000004172
Lead Sponsor
niversity of Yamanashi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

female during pregnancy active duplicated malignancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath